| Severe Acute Respiratory Syndrome Coronavirus 2 | (SARS-CoV-2) |
| Centers for Disease Control | (CDC) |
| United States | (US) |
| Interleukin-6 | (IL-6) |
| Nuclear Factor Kappa Beta | (NF-κB) |
| COVID-19 Associated Mucormycosis | (CAM) |
| Diabetic Ketoacidosis | (DKA) |
| Intensive Care Unit | (ICU) |
| Hypoxia inducible factor-1α | (HIF-1α) |
| Angiotensin-converting enzyme-2 | (ACE-2) |
| Diabetes Mellitus | (DM) |
| Tumor necrosis factor-alpha | (TNF-α) |
| Interleukin-10 | (IL-10) |
| Interferon gamma | (IFN-ℽ) |
| T helper 1 cell | (Th1) |
| Invasive Pulmonary Aspergillosis | (IPA) |
| COVID-19 Associated Pulmonary Aspergillosis | (CAPA) |
| COVID-19 Associated Candidiasis | (CAC) |
| Oropharyngeal Candidiasis | (OPC) |
| Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome | (HIV/AIDS) |
| Shortness of breath | (SOB) |
| Headache | (HA) |
| Gastrointestinal | (GI) |
| Thymosin alpha 1 | (Tα1) |
| All Trans Retinoic Acid | (ATRA) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.